A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Efficacy of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years
about
A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Efficacy of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study to Evaluate the Pharma ...... eater Than or Equal to 6 Years
@en
type
label
A Study to Evaluate the Pharma ...... eater Than or Equal to 6 Years
@en
prefLabel
A Study to Evaluate the Pharma ...... eater Than or Equal to 6 Years
@en
P17
P4844
P1476
A Phase II, Open Label, Single ...... hildren Aged >= 6 to <18 Years
@en
P3098
NCT00799864
P580
2011-01-07T00:00:00Z
P582
2020-01-10T00:00:00Z